Melodiol Global Health COPHF Stock
Melodiol Global Health Price Chart
Melodiol Global Health COPHF Financial and Trading Overview
Melodiol Global Health stock price | 0.12 USD |
Previous Close | 0.0099 USD |
Open | 0.01 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.01 - 0.01 USD |
52 Week Range | 0.0012 - 0.1 USD |
Volume | 10K USD |
Avg. Volume | 972.2K USD |
Market Cap | 25.67M USD |
Beta (5Y Monthly) | 2.597701 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
COPHF Valuation Measures
Enterprise Value | 26.43M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.8788404 |
Price/Book (mrq) | 0.8333333 |
Enterprise Value/Revenue | 2.964 |
Enterprise Value/EBITDA | -1.577 |
Trading Information
Melodiol Global Health Stock Price History
Beta (5Y Monthly) | 2.597701 |
52-Week Change | -68.94% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.1 USD |
52 Week Low | 0.0012 USD |
50-Day Moving Average | 0.01 USD |
200-Day Moving Average | 0.01 USD |
COPHF Share Statistics
Avg. Volume (3 month) | 972.2K USD |
Avg. Daily Volume (10-Days) | 2.41M USD |
Shares Outstanding | 2.57B |
Float | 1.53B |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -216.90% |
Gross Margin | 1.22% |
EBITDA Margin | -188.0020% |
Management Effectiveness
Return on Assets (ttm) | -35.93% |
Return on Equity (ttm) | -130.98% |
Income Statement
Revenue (ttm) | 8.92M USD |
Revenue Per Share (ttm) | 0.006 USD |
Quarterly Revenue Growth (yoy) | 43.60% |
Gross Profit (ttm) | 219K USD |
EBITDA | -16766000 USD |
Net Income Avi to Common (ttm) | -32782000 USD |
Diluted EPS (ttm) | -0.02 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.39M USD |
Total Cash Per Share (mrq) | 0.001 USD |
Total Debt (mrq) | 6.67M USD |
Total Debt/Equity (mrq) | 29.92 USD |
Current Ratio (mrq) | 0.757 |
Book Value Per Share (mrq) | 0.012 |
Cash Flow Statement
Operating Cash Flow (ttm) | -17306000 USD |
Levered Free Cash Flow (ttm) | -6851000 USD |
Profile of Melodiol Global Health
Country | United States |
State | WA |
City | Nedlands |
Address | 145 Stirling Highway |
ZIP | 6009 |
Phone | 61 8 9389 3180 |
Website | https://melodiolglobalhealth.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser. In addition, the company develops Halucenex, which is in phase II clinical trials, which will test the efficacy of psilocybin on treatment of resistant Post Traumatic Stress Disorder. Further, it engages in marketing of its hemp based food, feed supplements, and topical products; manufacture and sale of packaged consumer products; conducts clinical trial and development of synthetic psilocybin micro and macro dose formulations to treat treatment resistant depression and anxiety; and development of psychedelic medicines. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
Q&A For Melodiol Global Health Stock
What is a current COPHF stock price?
Melodiol Global Health COPHF stock price today per share is 0.12 USD.
How to purchase Melodiol Global Health stock?
You can buy COPHF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Melodiol Global Health?
The stock symbol or ticker of Melodiol Global Health is COPHF.
Which industry does the Melodiol Global Health company belong to?
The Melodiol Global Health industry is Drug Manufacturers-Specialty & Generic.
How many shares does Melodiol Global Health have in circulation?
The max supply of Melodiol Global Health shares is 1.13B.
What is Melodiol Global Health Price to Earnings Ratio (PE Ratio)?
Melodiol Global Health PE Ratio is 0.00000000 now.
What was Melodiol Global Health earnings per share over the trailing 12 months (TTM)?
Melodiol Global Health EPS is 0 USD over the trailing 12 months.
Which sector does the Melodiol Global Health company belong to?
The Melodiol Global Health sector is Healthcare.